INBS
Intelligent Bio Solutions Inc. (NASDAQ)
Healthcare — Medical Devices
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Price History
Fundamentals
| Market Cap | $5.33M |
| P/E Ratio (TTM) | - |
| Forward P/E | 6.37 |
| EPS (TTM) | $-11.62 |
| Dividend Yield | - |
| Profit Margin | -296.77% |
| Revenue Growth | 45.50% |
| ROE | -170.19% |
| Debt/Equity | 21.12 |
| Recommendation | Strong Buy 1.0 |
| Analyst Target | $12.00 |
| Analysts | 1 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 42.8 |
| Beta | 4.18 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $24.90 |
| 52-Week Low | $2.08 |
| 50-Day Avg | $2.60 |
| 200-Day Avg | $6.35 |
| Avg Volume | 108.0K |
| Volume | 38.4K |
Performance Analysis
BULLISHINBS shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:15 UTC
Back to Screener Export Report